Previous studies utilizing small groups of PD patients have demonstrated that co-administration of salbutamol (a β2-AR agonist) with levodopa helps reduce parkinsonian symptoms (Alexander et al., 1994; Uc et al., 2003). The gene discussed is ADRB2; the disease is Parkinson disease.